Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 190 of 6351
-
Could a higher dose of rifampicin cut TB treatment time for kids?
Cure Not yet recruitingCurrent tuberculosis (TB) treatment is effective (works well), but it takes a long time to cure TB. This study will evaluate if TB treatment with a higher dose of rifampicin, one of the TB medicines, and shorter TB treatment duration is as effective and safe as the standard, TB t…
Phase 2 • Sponsor: University of Wisconsin, Madison • Aim: Cure
Last updated Jun 27, 2026 14:00 UTC
-
Selective cell removal may tame stem cell Transplant's dangerous side effect
Disease control Not yet recruitingThis phase II trial investigates how well a naive T cell depleted graft work for the reduction of graft versus host disease in patients with non-malignant diseases requiring hematopoietic cell transplantation. Giving chemotherapy and total-body irradiation before a donor peripher…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a common diabetes drug stop diabetes after kidney transplant?
Prevention Not yet recruitingThe goal of this clinical trial is to find out whether 12 months of treatment with the SGLT2 inhibitor Forxiga® (dapagliflozin 10 mg once daily), compared with placebo, can reduce the risk of developing post-transplant diabetes in kidney transplant recipients who do not have diab…
Phase 2 • Sponsor: Odense University Hospital • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
Spinal implant and Mind-Controlled rehab may restore arm movement after stroke
Disease control Not yet recruitingThis clinical study aims to evaluate the efficacy and safety of spinal cord stimulation combined with non-invasive motor imagery brain-computer interface rehabilitation training in patients with upper limb motor dysfunction after chronic stroke. The study includes an experimental…
Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Gut bacteria transplant may supercharge liver cancer immunotherapy
Disease control Not yet recruitingHepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide and is frequently diagnosed at an advanced stage, resulting in limited therapeutic options. Despite the advances in immunotherapy, a substantial proportion of patients fail to respon…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Weight-Loss drug tirzepatide may help keep heart rhythm steady after ablation
Disease control Not yet recruitingObese patients with atrial fibrillation (AF) have a high recurrence rate after catheter ablation, even at experienced centers. Weight reduction improves post-ablation outcomes, but lifestyle measures alone are difficult to sustain. Tirzepatide, a once-weekly GIP/GLP-1 dual recept…
Phase 4 • Sponsor: Yunlong Wang • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can insulin or a diabetes drug boost Alzheimer's treatment?
Disease control Not yet recruitingThe purpose of this study is to find out what effects (good and bad) the study medications (insulin or Empagliflozin) have on adults with mild memory impairment or early Alzheimer's disease who are clinically prescribed an anti-amyloid therapy compared to placebo.
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can umbilical cord stem cells repair diabetic kidneys?
Disease control Not yet recruitingDiabetic nephropathy (DN) is a chronic kidney disease caused by diabetes. It is one of the most common and most serious microvascular complications of diabetes. Current treatment options for DN are limited. Mesenchymal stem cells (MSCs) are considered one of the promising treatme…
Phase 1/2 • Sponsor: The First People's Hospital of Changzhou • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a new eye drop soothe the burning dryness of ocular GVHD?
Disease control Recruiting nowThis is a Phase III, multicenter, randomized, double-masked, vehicle-controlled, parallel-group clinical trial designed to evaluate the efficacy, safety, and tolerability of d-MAPPS™ Ophthalmic Solution in adult subjects with chronic ocular graft-versus-host disease (oGVHD). Elig…
Phase 3 • Sponsor: Regenerative Ocular Immunobiologics LLC • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a pill replace IV drips for a hidden bone infection?
Disease control Not yet recruitingBrucellosis is a globally distributed zoonosis with persistent clinical management challenges. The World Health Organization(WHO)-recommended doxycycline-rifampin (DOX-RIF) dual regimen may drive rifampin-associated antimicrobial resistance across all brucellosis-endemic regions.…
Sponsor: The First Affiliated Hospital of Shihezi University • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a smart algorithm keep depression from returning?
Disease control Not yet recruitingThis proposal seeks to carry out a prospective, single-arm open label study aimed at sustaining treatment-resistant depression (TRD) response in patients with TRD who had responded to prior individualized resting-state functional connectivity (rs-FC)-guided intermittent theta bur…
Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could cannabis oil be a new key to chronic pain relief and stronger bones in women?
Symptom relief Not yet recruitingChronic pain disproportionately affects women and may coexist with impaired bone health, particularly during midlife and after menopause. The endocannabinoid system is involved in pain modulation and bone homeostasis; however, clinical studies that integrate pain outcomes, bone-r…
Phase 2 • Sponsor: Associação Pan-Americana Multidisciplinar de Endocanabinologia • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Can an oral pill tame a rare blood disease?
Disease control Not yet recruitingThis study aimed to evaluate the efficacy and safety of Lanoracopan Hydrochloride in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a daily mineral make liver cancer therapy work better?
Disease control Not yet recruitingThis study will look at whether adding daily oral zinc supplements to targeted therapy plus immunotherapy may help people with unresectable or advanced hepatocellular carcinoma, a common type of liver cancer. About 60 participants will take part in this study. Participants will …
Phase 2 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a new drug shrink Hard-to-Treat gynecological tumors?
Disease control Not yet recruitingThis Phase Ib/II study is a clinical study to explore the efficacy and safety of BL-M08D1 for injection in patients with recurrent or metastatic gynecological tumors and other solid tumors.
Phase 1/2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a new drug combo shrink High-Risk throat tumors?
Disease control Not yet recruitingThis Phase II study is a clinical trial exploring the efficacy and safety of BL-B01D1 with or without PD-1 monoclonal antibody in patients with high-risk locally advanced nasopharyngeal carcinoma.
Phase 2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a gentle robotic pull retrain balance after stroke?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if a treadmill gait training performed with a new robotic device will improve walking balance and everyday participation in walking activities for adults who have had a stroke. The main questions it aims to answer are: 1. Does treadmil…
Sponsor: Northwestern University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can pairing ketamine with talk therapy beat depression alone?
Disease control Not yet recruitingThe goal of this clinical trial is to see if combining ketamine with behavioral activation (BA) therapy to treat moderate to severe treatment-resistant depression improves depressive symptoms and general functioning more than ketamine alone. We aim to find out whether participan…
Phase 2/3 • Sponsor: The Royal's Institute of Mental Health Research • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
A Hormone-Free IVF path? Lab-Matured eggs put to the test
Disease control Recruiting nowThis study is testing whether eggs can be collected from small follicles without using the usual ovarian stimulation medications. Participants will have up to three egg retrieval procedures. The eggs collected during each retrieval will be matured in the laboratory using the CAPA…
Sponsor: Kevin Doody • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
Can a Two-Drug combo quiet the tremors Parkinson's patients still feel?
Disease control Not yet recruitingVista PD is a randomized, placebo-controlled, multicenter study to evaluate the efficacy, PK, safety, and tolerability of VIM0423 in adults with Parkinson's disease tremor insufficiently responsive to dopaminergic therapy. The main objectives of this clinical trial are to determ…
Phase 2 • Sponsor: Vima Therapeutics • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC